Literature DB >> 24565742

Microstructure of β-zone parapapillary atrophy and rate of retinal nerve fiber layer thinning in primary open-angle glaucoma.

Yong Woo Kim1, Eun Ji Lee2, Tae-Woo Kim3, Mijin Kim3, Hyunjoong Kim4.   

Abstract

OBJECTIVE: To investigate whether the rate of retinal nerve fiber layer (RNFL) thinning differs according to the microstructure of β-zone parapapillary atrophy (PPA) as evaluated by spectral-domain (SD) optical coherence tomography (OCT) in primary open-angle glaucoma (POAG).
DESIGN: Prospective, observational, comparative study. PARTICIPANTS: A total of 195 eyes with POAG that had been evaluated by serial SD-OCT RNFL thickness measurements for ≥ 2 years.
METHODS: On the basis of the extent of Bruch's membrane (BM) within the β-zone PPA (area without retinal pigment epithelium [RPE]), as shown in the infrared fundus images, PPA was divided into PPA+BM (PPA with intact BM) and PPA-BM (PPA devoid of BM). Eyes were categorized into group A (having PPA+BM only, n=64), group B (having both PPA+BM and PPA-BM, n=58), group C (having PPA-BM only, n=32), and group D (without β-zone PPA, n=41). The rate of progressive OCT RNFL thinning was determined by linear regression and compared between groups. Factors influencing the rate of RNFL thinning were evaluated, including age, sex, follow-up duration, history of filtering surgery, baseline RNFL thickness, baseline intraocular pressure (IOP), mean IOP and IOP fluctuation during follow-up, PPA types, baseline PPA width, PPA width increase, axial length (AXL), central corneal thickness, and visual field mean deviation (MD). MAIN OUTCOME MEASURES: Rate of thinning of OCT RNFL thicknesses over time.
RESULTS: Patients in groups B and C were significantly younger and more myopic, and had a greater AXL, than those in groups A and D (all P<0.001). The rate of global RNFL thinning was significantly faster in group A (-1.66 ± 2.94 μm/year) than in the other groups (group B, -0.87 ± 1.28 μm/year; group C, 0.20 ± 1.86 μm/year; group D, -0.28 ± 1.74 μm/year; P = 0.001). Multivariate regression showed a significant association of shorter follow-up period (P = 0.016), greater baseline global RNFL thickness (P = 0.035), type of β-zone PPA (group A, P = 0.023), and greater baseline PPA+BM width (P = 0.034) with a faster rate of RNFL thinning.
CONCLUSIONS: The rate of RNFL thinning differed according to the microstructure of β-zone PPA. It was faster for eyes with β-zone PPA with intact BM than for eyes without β-zone PPA or with β-zone PPA devoid of BM.
Copyright © 2014 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24565742     DOI: 10.1016/j.ophtha.2014.01.008

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  30 in total

1.  Structural dissociation of optic disc margin components with optic disc tilting: a spectral domain optical coherence tomography study.

Authors:  Tomoko Hasegawa; Tadamichi Akagi; Masanori Hangai; Hiroshi Yamada; Kenji Suda; Yugo Kimura; Hideo Nakanishi; Hanako Ohashi Ikeda; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-18       Impact factor: 3.117

2.  Longitudinal change in choroidal thickness after trabeculectomy in primary open-angle glaucoma patients.

Authors:  Munemitsu Yoshikawa; Tadamichi Akagi; Hideo Nakanishi; Hanako Ohashi Ikeda; Satoshi Morooka; Hiroshi Yamada; Tomoko Hasegawa; Yuto Iida; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2016-10-03       Impact factor: 2.447

3.  Evaluation of Parapapillary Choroidal Microvasculature Dropout and Progressive Retinal Nerve Fiber Layer Thinning in Patients With Glaucoma.

Authors:  Ji-Ah Kim; Eun Ji Lee; Tae-Woo Kim
Journal:  JAMA Ophthalmol       Date:  2019-07-01       Impact factor: 7.389

4.  β-Zone Parapapillary Atrophy and Rates of Glaucomatous Visual Field Progression: African Descent and Glaucoma Evaluation Study.

Authors:  C Gustavo De Moraes; James T Murphy; Chad M Kaplan; Jeremy J Reimann; Alon Skaat; Dana M Blumberg; Lama Al-Aswad; George A Cioffi; Christopher A Girkin; Felipe A Medeiros; Robert N Weinreb; Linda Zangwill; Jeffrey M Liebmann
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

5.  The choroidal microvasculature of the parapapillary area as a biomarker of glaucoma development in the fellow eye of patients with unilateral glaucoma.

Authors:  Sangyoon Kim; Je Hyun Seo; Keunheung Park; Jonghoon Shin
Journal:  Int Ophthalmol       Date:  2022-07-25       Impact factor: 2.029

6.  Predictive Modeling of Long-Term Glaucoma Progression Based on Initial Ophthalmic Data and Optic Nerve Head Characteristics.

Authors:  Eun Ji Lee; Tae-Woo Kim; Jeong-Ah Kim; Seung Hyen Lee; Hyunjoong Kim
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

7.  Automated Beta Zone Parapapillary Area Measurement to Differentiate Between Healthy and Glaucoma Eyes.

Authors:  Patricia Isabel C Manalastas; Akram Belghith; Robert N Weinreb; Jost B Jonas; Min Hee Suh; Adeleh Yarmohammadi; Felipe A Medeiros; Christopher A Girkin; Jeffrey M Liebmann; Linda M Zangwill
Journal:  Am J Ophthalmol       Date:  2018-05-09       Impact factor: 5.258

8.  Juxtapapillary Deep-Layer Microvasculature Dropout and Retinal Nerve Fiber Layer Thinning in Glaucoma.

Authors:  Ji Min Kwon; Robert N Weinreb; Linda M Zangwill; Min Hee Suh
Journal:  Am J Ophthalmol       Date:  2021-02-22       Impact factor: 5.488

9.  Macular Bruch's Membrane Length and Axial Length. The Beijing Eye Study.

Authors:  Jost B Jonas; Ya Xing Wang; Qi Zhang; Yi Liu; Liang Xu; Wen Bin Wei
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

10.  The Relationship between Corvis ST Tonometry and Ocular Response Analyzer Measurements in Eyes with Glaucoma.

Authors:  Masato Matsuura; Kazunori Hirasawa; Hiroshi Murata; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.